In the News
Increased Capacity at Obiter Research
Press Release, September 08, 2016
CHAMPAIGN, Illinois - Clinical trials have been underway for the development of new drugs to combat major diseases such as Multiple Sclerosis, Cystic Fibrosis, Lupus and Pediatric Epilepsies. A common chemical intermediate used in the manufacture of these particular new drugs is (+)-p-mentha-2,8-dien-1-ol or (PMD). PMD is difficult to produce in bulk, and there are a limited number of manufacturers available in the United States..
Wired In: Bill Boulanger
The News-Gazette June 26, 2016
CHAMPAIGN - On Sundays, staff writer Paul Wood spotlights a high-tech difference maker. This week, Bill Boulanger, 63, the founder of Obiter Research, which manufactures complex chemical compounds for industries such as pharmaceuticals.
Obiter changes business model to adapt
The News-Gazette December 7, 2014
CHAMPAIGN - In the labs and offices of Obiter Research, chemist Bill Boulanger and his brother Chad are refining their formula for business success.
Obiter Research, a maker of specialty chemicals, has been in business since 2001. The company moved into a new $4 million research facility in Champaign's Apollo industrial park in 2007.
CAS and Obiter Research form a multi-year collaboration to provide SciFinder® to their research team
PRNewswire October 2014
COLUMBUS, Ohio, -- Chemical Abstracts Service (CAS), the world's authority for chemical information, today announced a collaboration with Obiter Research, a custom contract chemical research and manufacturing company, to provide SciFinder, the choice for chemistry research, for the Obiter research staff, resuming their access to the most accurate, comprehensive and current source of chemical and related scientific information.
Obiter Research specializes in complex, multi-step synthesis of custom chemical compounds for pharmaceutical, agrochemical and biotechnology companies as well as academic institutions. With exceptionally high success rates in difficult process and preparative chemistry, Obiter is expanding the contract manufacturing branch of its business.
Obiter Research honored for work safety
The News-Gazette October 2012
CHAMPAIGN — The director of the Illinois Department of Labor called Obiter Research "second to none in the safety of workers" as he presented an award Wednesday to the Champaign-based specialty-chemical maker.
Labor Director Joseph Costigan said Obiter Research was the 27th company in Illinois to qualify for an award from the Safety and Health Achievement Recognition Program, known as SHARP.
That program — an initiative of the U.S. Occupational Safety and Health Administration — honors businesses with exemplary safety and health programs.
The Right Chemistry - Champaign lab hopes anti-addictive compaound pays off
The News-Gazette December 2010
CHAMPAIGN - Bill Boulanger hopes a chemical compound that can cure addictionswith a single treatment will mean long-term prosperity for his company.
Boulanger, the founder of Obiter Research in Champaign, has licensed technology for the substance - called 18-MC - from Albany Medical College and the University of Vermont.
The substance, a synthetic derivative of naturally occurring ibogaine, appears promising in curing addictions to methamphetamine, heroin, nicotine and alcohol.
Addiction Cure - hallucinogen or help addicts kick their drug habits.
The Riverfront Times November 2010
Ibogaine is a hallucinogen that has helped addicts kick their drug habits. Is it the trip that does the trick?
Extracted from the root bark of the tabernathe iboga plant, ibogaine is a potent hallucinogen — with an intriguing side effect.
Obiter Community - it's a continual learning process, it's fun.
Champaign County Chamber of Commerce, 2007
Obiter Research, a Champaign based chemical research and development company, got it's start at the University of Illinois' Small Business Incubator in the Research Park. Five years later, the company has 13 staff members, nine of whom are scientists, housed in a new 20,000- square-foot building in Apollo Park.